Using data from a publicly available high-throughput cancer cell line drug screening dataset, GDSC1 [38], we found significant correlations between the IC50 values of cisplatin and doxorubicin and ANRIL expression (Supplementary Figure S1) in a collection of cancer cell lines. This evidence concerns the gene CDKN2B-AS1 and cancer.